{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:54:14Z","timestamp":1790067254002,"version":"4.0.1"},"reference-count":99,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Faculty of Veterinary Medicine"},{"DOI":"10.13039\/501100001829","name":"Utrecht University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001829","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Netherlands Institute of Mental Health and Addiction"},{"name":"Brijder Addiction Care Center"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","europeanneuropsychopharmacology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.euroneuro.2014.05.008","type":"journal-article","created":{"date-parts":[[2014,5,20]],"date-time":"2014-05-20T07:48:55Z","timestamp":1400572135000},"page":"1309-1323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Hallucinogen persisting perception disorder and the serotonergic system: A comprehensive review including new MDMA-related clinical cases"],"prefix":"10.1016","volume":"24","author":[{"given":"Ruud P.W.","family":"Litjens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tibor M.","family":"Brunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard-Jan","family":"Alderliefste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remco H.S.","family":"Westerink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2014.05.008_bib1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.optm.2009.12.010","article-title":"Palinopsia","volume":"81","author":"Abert","year":"2010","journal-title":"Optometry"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib2","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1001\/archpsyc.1983.01790070074009","article-title":"Visual phenomenology of the LSD flashback","volume":"40","author":"Abraham","year":"1983","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib3","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1360-0443.1993.tb02018.x","article-title":"Adverse consequences of lysergic acid diethylamide","volume":"88","author":"Abraham","year":"1993","journal-title":"Addiction"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0925-4927(96)02833-8","article-title":"Stable quantitative EEG difference in post-LSD visual disorder by split-half analysis: evidence for disinhibition","volume":"67","author":"Abraham","year":"1996","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0925-4927(01)00098-1","article-title":"EEG coherence in post-LSD visual hallucinations","volume":"107","author":"Abraham","year":"2001","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib6","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/00004714-199606000-00008","article-title":"LSD-like panic from risperidone in post-LSD visual disorder","volume":"16","author":"Abraham","year":"1996","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib7","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1037\/0021-843X.97.4.443","article-title":"Visual function in past users of LSD: psychophysical findings","volume":"97","author":"Abraham","year":"1988","journal-title":"J. Abnorm. Psychol."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib8","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR","author":"APA, DSM-IV","year":"2000"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1081\/ADA-120029870","article-title":"Barriers to enrollment in drug abuse treatment and suggestions for reducing them: opinions of drug injecting street outreach clients and other system stakeholders","volume":"30","author":"Appel","year":"2004","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib10","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1176\/ajp.127.9.1233","article-title":"\u201cTrailing\u201d phenomenon \u2013 a long-lasting LSD side effect","volume":"127","author":"Asher","year":"1971","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.drugalcdep.2010.09.006","article-title":"Abnormal visual experiences in individuals with histories of hallucinogen use: a web-based questionnaire","volume":"114","author":"Baggott","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/15622970209150621","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive\u2013compulsive and posttraumatic stress disorders","volume":"3","author":"Bandelow","year":"2002","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib13","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/npp.2010.244","article-title":"Human Ecstasy use is associated with increased cortical excitability: an fMRI study","volume":"36","author":"Bauernfeind","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib14","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/468630a","article-title":"Neuroscience: patterns from the brain","volume":"468","author":"Billock","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib15","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1037\/a0027580","article-title":"Elementary visual hallucinations and their relationships to neural pattern-forming mechanisms","volume":"138","author":"Billock","year":"2012","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib16","series-title":"Perception, International","year":"2006"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1162\/089976602317250861","article-title":"What geometric visual hallucinations tell us about the visual cortex","volume":"14","author":"Bressloff","year":"2002","journal-title":"Neural Comput."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib18","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s10072-012-1274-8","article-title":"Primary visual cortex excitability in migraine: a systematic review with meta-analysis","volume":"34","author":"Brigo","year":"2013","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib19","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1113\/jphysiol.1962.sp007011","article-title":"Two new properties of foveal after-images and a photochemical hypothesis to explain them","volume":"164","author":"Brindley","year":"1962","journal-title":"J. Physiol."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib20","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00213-011-2529-4","article-title":"Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users","volume":"220","author":"Brunt","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib21","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3109\/14659890903271624","article-title":"User perceptions of the benefits and harms of hallucinogenic drug use: a web-based questionnaire study","volume":"15","author":"Carhart-Harris","year":"2010","journal-title":"J. Subst. Use"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib22","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1093\/brain\/awr157","article-title":"Sustained visual cortex hyperexcitability in migraine with persistent visual aura","volume":"134","author":"Chen","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib23","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0140-6736(55)91156-9","article-title":"Hallucinogenic drugs","volume":"268","author":"Cooper","year":"1955","journal-title":"Lancet"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/(SICI)1096-9861(19990628)409:2<187::AID-CNE2>3.0.CO;2-P","article-title":"Cellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of adult rat","volume":"409","author":"Cornea-Hebert","year":"1999","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib25","doi-asserted-by":"crossref","first-page":"e27206","DOI":"10.1371\/journal.pone.0027206","article-title":"The influence of genetic and environmental factors among MDMA users in cognitive performance","volume":"6","author":"Cuyas","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib26","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00213-011-2412-3","article-title":"Endocannabinoid CB1 receptors modulate visual output from the thalamus","volume":"219","author":"Dasilva","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib27","doi-asserted-by":"crossref","first-page":"e1001056","DOI":"10.1371\/journal.pbio.1001056","article-title":"Visual trails: do the doors of perception open periodically","volume":"9","author":"Dubois","year":"2011","journal-title":"PLoS Biol."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neuropharm.2011.08.044","article-title":"Signaling pathways underlying the rapid antidepressant actions of ketamine","volume":"62","author":"Duman","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib29","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.eplepsyres.2009.03.017","article-title":"Delusions, illusions and hallucinations in epilepsy: 2. Complex phenomena and psychosis","volume":"85","author":"Elliott","year":"2009","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib30","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.5665\/sleep.2230","article-title":"Sleep deprivation increases cerebral serotonin 2A receptor binding in humans","volume":"35","author":"Elmenhorst","year":"2012","journal-title":"Sleep"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib31","unstructured":"EMCDDA, 2011. Annual report 2011. The State of the Drugs Problem in Europe."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib32","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1080\/02699931.2012.689953","article-title":"Anxiety modulates the effects of emotion and attention on early vision","volume":"27","author":"Ferneyhough","year":"2013","journal-title":"Cogn. Emot."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/syn.21626","article-title":"Cannabinoid receptor agonists upregulate and enhance serotonin 2A (5-HT(2A)) receptor activity via ERK1\/2 signaling","volume":"67","author":"Franklin","year":"2013","journal-title":"Synapse"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib34","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1055\/s-2003-38173","article-title":"Persisting visual hallucinations and illusions in previously drug-addicted patients","volume":"220","author":"Gaillard","year":"2003","journal-title":"Klin. Monbl. Augenheilkd."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib35","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00213-009-1501-z","article-title":"Comparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in rats","volume":"204","author":"Gatch","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib36","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.tips.2008.06.006","article-title":"Serotonin research: contributions to understanding psychoses","volume":"29","author":"Geyer","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib37","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1016\/0024-3205(84)90436-3","article-title":"Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents","volume":"35","author":"Glennon","year":"1984","journal-title":"Life Sci."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib38","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1037\/1064-1297.8.3.415","article-title":"A three-choice discrimination procedure dissociates the discriminative stimulus effects of d-amphetamine and (+\/\u2212)-MDMA in rats","volume":"8","author":"Goodwin","year":"2000","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib39","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1124\/pr.55.3.3","article-title":"The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, \u2018ecstasy\u2019)","volume":"55","author":"Green","year":"2003","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib40","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0376-8716(02)00306-X","article-title":"Hallucinogen persisting perception disorder: what do we know after 50 years","volume":"69","author":"Halpern","year":"2003","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib41","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1017\/S1461145705005651","article-title":"Altered responsiveness of serotonin receptor subtypes following long-term cannabinoid treatment","volume":"9","author":"Hill","year":"2006","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib42","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF00343238","article-title":"Flashbacks: a personal follow-up","volume":"222","author":"Holsten","year":"1976","journal-title":"Arch. Psychiatr. Nervenkr."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib43","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/archopht.1990.01070050097040","article-title":"Trazodone-induced palinopsia","volume":"108","author":"Hughes","year":"1990","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib44","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.drugalcdep.2011.10.029","article-title":"Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers","volume":"123","author":"Johnson","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib45","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10827-011-0335-y","article-title":"Hallucinogen persisting perception disorder in neuronal networks with adaptation","volume":"32","author":"Kilpatrick","year":"2012","journal-title":"J. Comput. Neurosci."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib46","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1093\/brain\/awq103","article-title":"Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography\/[(11)C]DASB and structural brain imaging study","volume":"133","author":"Kish","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib47","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/schbul\/3.4.560","article-title":"A comparison of the phenomenology of hallucinogens and schizophrenia from some autobiographical accounts","volume":"3","author":"Kleinman","year":"1977","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00004850-200015010-00005","article-title":"LSD-induced hallucinogen persisting perception disorder treatment with clonidine: an open pilot study","volume":"15","author":"Lerner","year":"2000","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib49","first-page":"92","article-title":"Flashback and hallucinogen persisting perception disorder: clinical aspects and pharmacological treatment approach","volume":"39","author":"Lerner","year":"2002","journal-title":"Isr. J. Psychiatry Relat. Sci."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib50","first-page":"25","article-title":"Benign and time-limited visual disturbances (flashbacks) in recent abstinent high-potency heavy cannabis smokers: a case series study","volume":"48","author":"Lerner","year":"2011","journal-title":"Isr. J. Psychiatry Relat. Sci."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib51","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0893-133X(99)00148-7","article-title":"Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, \u2018Ecstasy\u2019) are attenuated by the serotonin uptake inhibitor citalopram","volume":"22","author":"Liechti","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib52","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1212\/WNL.45.4.664","article-title":"Persistent positive visual phenomena in migraine","volume":"45","author":"Liu","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib53","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/brain\/121.10.1819","article-title":"Complex visual hallucinations. Clinical and neurobiological insights","volume":"121","author":"Manford","year":"1998","journal-title":"Brain"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib54","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0022-3476(06)80189-7","article-title":"LSD flashback syndrome exacerbated by selective serotonin reuptake inhibitor antidepressants in adolescents","volume":"125","author":"Markel","year":"1994","journal-title":"J. Pediatr."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib55","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000095816","article-title":"5-Year trends in use of hallucinogens and other adjunct drugs among UK dance drug users","volume":"13","author":"McCambridge","year":"2007","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib56","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1038\/sj.npp.1300736","article-title":"Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB","volume":"30","author":"McCann","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib57","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/archpsyc.1971.01750070037005","article-title":"LSD revisited. A ten-year follow-up of medical LSD use","volume":"24","author":"McGlothlin","year":"1971","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib58","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1111\/j.1476-5381.2009.00434.x","article-title":"Effect of the CB(1) receptor antagonists rimonabant and AM251 on the firing rate of dorsal raphe nucleus neurons in rat brain slices","volume":"158","author":"Mendiguren","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib59","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00004714-199708000-00020","article-title":"Exacerbation of hallucinogen-persisting perception disorder with risperidone","volume":"17","author":"Morehead","year":"1997","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib60","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/hup.2218","article-title":"Residual effects of ecstasy (3,4-methylenedioxymethamphetamine) on low level visual processes","volume":"27","author":"Murray","year":"2012","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib61","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0893-133X(01)00405-5","article-title":"A single dose of lysergic acid diethylamide influences gene expression patterns within the mammalian brain","volume":"26","author":"Nichols","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib62","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pharmthera.2003.11.002","article-title":"Hallucinogens","volume":"101","author":"Nichols","year":"2004","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib63","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(07)60464-4","article-title":"Development of a rational scale to assess the harm of drugs of potential misuse","volume":"369","author":"Nutt","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib64","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/S0140-6736(10)61462-6","article-title":"Drug harms in the UK: a multicriteria decision analysis","volume":"376","author":"Nutt","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib65","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1684\/j.1950-6945.1999.tb00326.x","article-title":"Visual phenomena and headache in occipital epilepsy: a review, a systematic study and differentiation from migraine","volume":"1","author":"Panayiotopoulos","year":"1999","journal-title":"Epileptic Disord."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib66","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0006-8993(00)03193-0","article-title":"Serotoninergic afferents preferentially innervate distinct subclasses of peptidergic interneurons in the rat visual cortex","volume":"891","author":"Paspalas","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib67","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1755-5949.2008.00059.x","article-title":"The pharmacology of lysergic acid diethylamide: a review","volume":"14","author":"Passie","year":"2008","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib68","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1046\/j.1440-1614.2002.t01-1-01016.x","article-title":"Persisting continuous visual perception disorder in a chronic MDMA (\u2018ecstasy\u2019) user","volume":"36","author":"Passie","year":"2002","journal-title":"Aust. N Z J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib69","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/1355621021000005937","article-title":"The pharmacology of psilocybin","volume":"7","author":"Passie","year":"2002","journal-title":"Addict. Biol."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib70","article-title":"Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 2h apart","author":"Peiro","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib71","first-page":"16","article-title":"Developmental changes in GABAergic mechanisms in human visual cortex across the lifespan","volume":"4","author":"Pinto","year":"2010","journal-title":"Front Cell Neurosci."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib72","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/archopht.1995.01100040102034","article-title":"Visual disturbance secondary to clomiphene citrate","volume":"113","author":"Purvin","year":"1995","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib73","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.drugalcdep.2009.09.014","article-title":"Typology of club drug use among young adults recruited using time-space sampling","volume":"107","author":"Ramo","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib74","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0893-133X(01)00366-9","article-title":"The acute and chronic effects of MDMA (\u2018ecstasy\u2019) on cortical 5-HT2A receptors in rat and human brain","volume":"26","author":"Reneman","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib75","doi-asserted-by":"crossref","first-page":"854","DOI":"10.3109\/10408444.2012.725029","article-title":"Pharmacokinetics and pharmacodynamics of 3,4-methylenedioxymethamphetamine (MDMA): interindividual differences due to polymorphisms and drug-drug interactions","volume":"42","author":"Rietjens","year":"2012","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib76","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1467-8659.2012.03053.x","article-title":"A computational model of afterimages","volume":"31","author":"Ritschel","year":"2012","journal-title":"Comput. Graph. Forum"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib77","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/WNO.0b013e318064e4db","article-title":"Palinopsia from posterior visual pathway lesions without visual field defects","volume":"27","author":"Ritsema","year":"2007","journal-title":"J. Neuroophthalmol."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib78","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/26475","article-title":"Object-based attention in the primary visual cortex of the macaque monkey","volume":"395","author":"Roelfsema","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib79","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000338642","article-title":"CB1 and CB2 receptor expression and promoter methylation in patients with cannabis dependence","volume":"19","author":"Rotter","year":"2013","journal-title":"Eur. Addict. Res."},{"issue":"Pt 2","key":"10.1016\/j.euroneuro.2014.05.008_bib80","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/brain\/119.2.355","article-title":"A nosographic analysis of the migraine aura in a general population","volume":"119","author":"Russell","year":"1996","journal-title":"Brain"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib81","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0306-4522(99)00334-6","article-title":"Effects of blocking non-N-methyl-d-aspartate receptors on visual responses of neurons in the cat visual cortex","volume":"94","author":"Sato","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib82","doi-asserted-by":"crossref","unstructured":"Schankin, C., Maniyar, F., Hoffmann, J., Chou, D., Goadsby, P., 2013. Clinical characterization of \u2018visual snow\u2019 (positive persistent visual disturbance). The European Headache and Migraine Trust International Congress London, UK.","DOI":"10.1186\/1129-2377-1-S1-P132"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib83","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.euroneuro.2011.12.002","article-title":"Mapping serotonergic dysfunction in MDMA (ecstasy) users using pharmacological MRI","volume":"22","author":"Schouw","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib84","doi-asserted-by":"crossref","first-page":"11031","DOI":"10.1073\/pnas.1119527109","article-title":"Different glutamate receptors convey feedforward and recurrent processing in macaque V1","volume":"109","author":"Self","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib85","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.psychres.2011.12.017","article-title":"Depersonalization disorder and anxiety: a special relationship","volume":"197","author":"Sierra","year":"2012","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib86","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.4088\/JCP.08m04370","article-title":"Is depersonalization disorder initiated by illicit drug use any different? A survey of 394 adults","volume":"70","author":"Simeon","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib87","first-page":"1214","article-title":"Unfavourable reactions to LSD: a review and analysis of the available case reports","volume":"97","author":"Smart","year":"1967","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib88","doi-asserted-by":"crossref","first-page":"e30800","DOI":"10.1371\/journal.pone.0030800","article-title":"Prediction of psilocybin response in healthy volunteers","volume":"7","author":"Studerus","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib89","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4088\/PCC.08r00673","article-title":"Visual hallucinations: differential diagnosis and treatment","volume":"11","author":"Teeple","year":"2009","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib90","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF00176847","article-title":"Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens","volume":"94","author":"Titeler","year":"1988","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib91","unstructured":"van der Poel, A., Doekhie, J., Verdurmen, J., Wouters, M., Korf, D.J., van Laar, M., 2010. Feestmeter 2008\u20132009, Trimbos Report. Trimbos Institute, Utrecht."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib92","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/sj.npp.1395197","article-title":"Psychological and cardiovascular effects and short-term sequelae of MDMA (\u2018ecstasy\u2019) in MDMA-naive healthy volunteers","volume":"19","author":"Vollenweider","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib93","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1093\/cercor\/bhn219","article-title":"Enriched expression of serotonin 1B and 2A receptor genes in macaque visual cortex and their bidirectional modulatory effects on neuronal responses","volume":"19","author":"Watakabe","year":"2009","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib94","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0079-6123(03)14421-4","article-title":"Auras and other hallucinations: windows on the visual brain","volume":"144","author":"Wilkinson","year":"2004","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.euroneuro.2014.05.008_bib95","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00213-008-1356-8","article-title":"Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines","volume":"203","author":"Winter","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib96","doi-asserted-by":"crossref","first-page":"e53082","DOI":"10.1371\/journal.pone.0053082","article-title":"Developmental and visual input-dependent regulation of the CB1 cannabinoid receptor in the mouse visual cortex","volume":"8","author":"Yoneda","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib97","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuro.2011.11.001","article-title":"Mapping the central effects of chronic ketamine administration in an adolescent primate model by functional magnetic resonance imaging (fMRI)","volume":"33","author":"Yu","year":"2012","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib98","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/brain\/114.2.811","article-title":"Cerebral akinetopsia (visual motion blindness). A review","volume":"114","author":"Zeki","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.euroneuro.2014.05.008_bib99","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0924-977X(02)00108-6","article-title":"Architectonics of the human cerebral cortex and transmitter receptor fingerprints: reconciling functional neuroanatomy and neurochemistry","volume":"12","author":"Zilles","year":"2002","journal-title":"Eur. Neuropsychopharmacol."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X14001461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X14001461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T20:00:59Z","timestamp":1716753659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X14001461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":99,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0924977X14001461"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2014.05.008","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hallucinogen persisting perception disorder and the serotonergic system: A comprehensive review including new MDMA-related clinical cases","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2014.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}